(Maastricht category III) 3 are patients in intensive care units in which circulatory arrest is awaited after withdrawal from life-sustaining treatment. As opposed to DBD, the DCD procedure is accompanied with warm ischemia time preceding circulatory arrest, which may result in a higher incidence of primary non-function (PNF) and delayed graft function (DGF). There is limited evidence that the hemodynamics during the agonal phase-ie, the period between withdrawal of life-sustaining treatment and circulatory arrest-potentially exacerbate ischemia/reperfusion injury of the DCD kidney. If agonal phase parameters cause extra ischemic insult, these may be useful to predict recipient transplant outcome.
To minimize the potential impact of duration of agonal phase, our nationwide protocol from the Dutch Transplant Foundation recommends a cut-off of two hours. 4 However, consensus in US was set to one hour, and in UK the duration of agonal phase may be up to five hours (three hours before systolic BP < 50 mmHg, and two hours after systolic BP < 50 mmHg). In the UK, Reid et al 5 studied 117 DCD donors using a cut-off for the agonal phase of four hours, and found no association between duration of agonal phase and transplant outcome. It was Ho et al 6 who argued that agonal phase characteristics, including duration and severity of hemodynamic instability or hypoxia may be better predictors of graft function than just the agonal phase period. In another comprehensive study from the US, Allen et al 7 analyzed different hemodynamic measures to capture warm ischemic injury from extubation until cross-clamp of the aorta. Surprisingly, they did not find an association between SBP < 50 mmHg in minutes during agonal phase and outcome of DGF or graft failure. But as the authors stated, this was partly due to the nonlinear trajectory of SBP which underestimated the effect on DGF. Once solved by estimating Area Under the Curve (AUC) of SBP, it was found to be a significant predictor of DGF. This increased risk was not found for graft failure, implying that agonal phase characteristics have an immediate effect on the graft, but not on longer-term survival. 7 The duration of agonal phase and hemodynamic measures have not been evaluated in a program including elderly (≥65 y) DCD kidneys.
In this retrospective cohort study, we sought to address two research questions: (1) How is duration of agonal phase period associated with transplant outcome?; and (2) Can measures of systolic blood pressure and peripheral oxygenation during agonal phase predict transplant outcome?
2 | ME THODS
| Study population
Data were retrieved from Erasmus Medical Center and Academic
Medical Center (AMC), two Dutch transplant centers that are tertiary referral hospitals in Rotterdam and Amsterdam, respectively.
We included all adult (≥18) recipients (n = 409) of a renal allograft from a DCD Maastricht category III donor procured between January 1, 2006, and January 1, 2014. Patients were followed until May 1, 2015, or at the last known serum creatinine measurement.
| Measures
We evaluated several endpoints after transplantation: primary non- mismatch levels (no mismatch to up to six mismatches). Figure 1 depicts the definitions of measures for donor WIT. Agonal phase was defined as time from withdrawal of life-sustaining treatment to circulatory arrest. Parameters during agonal phase were dichotomized into minutes of SpO2 > 60% or SpO2 < 60%, and minutes of SBP > 80 mmHg or SBP < 80 mmHg. These limits were predefined by our transplant coordinators and registered as such in the registry. During agonal phase, transplant coordinators continuously monitored SpO 2 and SBP, and registered these with clock times in minutes in the Eurotransplant donor procedure application. Agonal phase measures were explicitly separated from first WIT, the time from circulatory arrest to cold perfusion within the hospital. CIT was defined as the time from start of cold perfusion to removal from ice for implantation. Anastomosis time was the time during implantation, from removal of the organ from ice until reperfusion. HLA mismatches were defined as the number of mismatches between donor and recipient of HLA-A, HLA-B, and HLA-DR combined.
| Donor criteria and proceedings of donation after circulatory death
Age limit for the DCD donor is set to 75 years. Permissible time of agonal phase between switch-off and circulatory arrest is restricted to 120 minutes. The duration of acceptable first WIT (time from circulatory arrest to start) is 30 minutes, including the obligatory five-minute no-touch period after circulatory arrest. After the obligatory five-minute no-touch period, the deceased was immediately transported to the operating room from the ICU, where surgical staff were waiting. A rapid laparotomy and direct cannulation of the aorta was then performed and organs were procured afterwards.
| Statistical analysis
We compared the donor and recipient characteristics of transplanted patients across the categories of duration of agonal phase.
We used logistic regression for the short-term transplant outcomes PNF and DGF. Kaplan-Meier curves were used, right-censored at three years, to estimate cumulative death-censored graft survival.
Cumulative incidence competing risk (CICR) functions were used to calculate unadjusted incidences of three-year graft survival, and to take into account the competing events of patient death, graft loss, and eGFR < 15 without further improvement over time. 8 Loss to follow-up was handled by censoring at the last known date of creatinine measurement at the hospital. We searched the literature for known donor and recipient risk factors that were associated with transplant outcomes of transplanting kidneys from donors after circulatory death. In addition, these variables had to be documented by either transplant coordinators in the two hospitals or electronic patient files or Eurotransplant data. We used these factors in a prediction model for PNF, DGF, and cause-specific
Cox-regression analysis. To avoid categorization, agonal phase period and agonal phase parameters were modelled with a 3-knot restricted cubic spline with pre-defined internal knots at the median and interquartile range (IQR). We used Wald tests to describe the effect of prolonged agonal phase period and its parameters, and to test for linearity. The presence of significance of interaction was evaluated, and Wald tests were used to estimate the joint effect of the interactions. Since duration of SBP < 80 mmHg and SpO2 < 60% are highly correlated, we conducted separate models to avoid multicollinearity.
The rate of missing agonal phase data was below 15.0%
( 
| RE SULTS

| Baseline characteristics
A total of 409 kidneys from category III DCD donors were transplanted between 2006 and 2014 (see Table 1 
| Period of agonal phase and graft failure
At 3 years after transplantation, patient death as first event was 7.1% (95% CI 4.7-10.1), whereas 15.6% (95% CI 12.1-12.1) had graft failure leading to dialysis, and 1.2% of patients (95% CI 0.5-2.7) had an eGFR below 15 mL/min at three months without further improvement. Delayed graft function was prevalent in 255 transplantations (67%), while excluding 27 cases (6.6%) of primary non-function.
There were 72 cases (15.8%) with agonal phase period exceeding 30 minutes, with only 19 cases (4.9%) exceeding 60 minutes and eight cases (2.1%) exceeding 90 minutes. If period of agonal phase was categorized into groups, death-censored graft failure at three years revealed no differences (P = .206) (see Figure 2 ). This is also depicted in Figure 3A : increase in agonal phase period was not associated with hazard on graft failure censored for death at three years (Wald P = .670), neither after adjustments (Wald P = .734). In TA B L E 1 Descriptive statistics of study cohort (n = 409 DCD kidney transplantations)
Donor parameters Median (IQR)/N (%) Missing (%)
Age ( 
TA B L E 1 (Continued)
Continues contrast, increase in period of agonal phase significantly predicted the odds of having delayed graft function (Wald P < .001). The effect remained significant after adjusting for covariates (Wald P = .016) (see Figure 3B ). An increase from 16.4 to 40 minutes in period of agonal phase was associated with 1.61 times the odds (95% CI 1.12-2.32, P = .010) for delayed graft function, and with a trend to significance for primary non-function (OR 1.56, 95% CI 0.99-2.49, P = .055) (see Figure 3C ).
| SBP during agonal phase and transplant outcomes
During the agonal phase, the initial period of SBP > 80 mmHg was longer than the period of SpO2 > 60% (seven min vs. four min, P < .001, respectively). Subsequently, the period SBP stayed <80 mmHg was shorter as compared to SpO2 < 60% (seven vs. 10 minutes, P < .001, respectively). Figure 4 shows the distribution of different trajectories for SBP and SpO2 from switch-off until circulatory arrest. In all three models restricted cubic splines were used to plot period of agonal phase with internal knots at 5, 15, and 40 minutes, and corresponding to a donor age of 55 years, cold ischemic time of 16 hours, three HLA mismatch levels, 16-minute first WIT, 30-minute anastomosis time, CVA as donor cause of death, 67 mL/ min last measured creatinine of the donor, multi-organ-donor, 3.6 years recipient dialysis vintage, and recipient age of 58 years. CVA, cerebrovascular accident; HLA, human leukocyte antigen and dialysis vintage per year prior to transplantation as significant contributors to predict DGF (P = .047, and P < .001, respectively).
Longer period of SBP < 80 mmHg was not significantly associated with long term graft survival and death-censored graft survival (Wald P = .399, Wald P = .596, respectively).
| SpO2 during agonal phase and transplant outcomes
Firstly, we tested interaction for SpO2 > 60% and SpO2 < 60% which was not significant for PNF and DGF (adjusted interaction OR 1.013, 95% CI 0.982-1.045, P = .418, and OR 1.006, 95% CI 0.947-1.069, P = .837, respectively). Hereafter, models tested the additive effect of longer periods of both SpO2 > 60% and SpO2 < 60%. Longer period of SpO2 < 60%-modelled with a 3-knot restricted cubic splinedid not contribute significantly to the prediction of PNF (P = .107), depicted in Figure 5B . Also the preceding period of SpO2 > 60% did not contribute to predict PNF. Longer period of SpO2 < 60% was also not significantly associated with DGF (P = .382, but this was the case for increasing period of SpO2 > 60% (P = .032). An increase from five minutes to 10 minutes in period of SpO2 > 60% was associated with 1.20 times the odds (95% CI 1.02-1.41, P = .029) for delayed graft function. Independent of both SpO2%, we also identified donor age per year, and dialysis vintage per year prior to transplantation as significant contributors to predict DGF (P < .032, P < .001, respectively). Longer period of SpO2 < 60% was not significantly associated with graft survival and death-censored graft survival (Wald P = .399, Wald P = .596, respectively).
| Measures for donor warm ischemic injury, donor age, and transplant outcomes
Functional WIT, starting from SBP < 80 mmHg to cold perfusion, significantly predicted DGF, while this was not significant if calculated from SpO2 < 60% to cold perfusion (see Table 2 ). Also the total WIT, starting from withdrawal life-sustaining treatment to cold perfusion, significantly predicted delayed graft function. These measures for WIT were not able to significantly predict primary non-function, renal function at three months, and graft failure at three year. Only time from asystole to cold perfusion predicted significantly primary non-function: an increase from 10 minutes to 20 minutes was associated with 7.69 times the odds (95% CI 1.01-58.72, P = .048).
With DGF as outcome, we sought to find associations of agonal phase and functional WIT-starting from SBP < 80 mmHg to cold perfusion-for different donor ages with interaction analyses.
Higher donor age attenuated the association of agonal phase as well as for functional WIT (see Table 3 ). These findings suggest that for DCD donor kidneys of 60 years and older, duration of agonal phase and functional WIT are relatively less relevant compared to younger donors with outcome of DGF ( Table 4 ).
| D ISCUSS I ON
The current study contributes to the existing knowledge about the donors' period of agonal phase, and measures of warm ischemic injury. In 409 DCD donor kidney transplantations, only eight cases exceeded 90 minutes of agonal phase which was within the limit of two hours. Longer periods of agonal phase were associated with a significantly increased risk of delayed graft function, and tended to an increased risk of primary non-function though this failed significance.
Agonal phase duration was not associated with death-censored graft failure at three years. We analyzed two frequently used parameters during agonal phase: minutes of SpO2 > 60% or SpO2 < 60%, and minutes of SBP > 80 mmHg or SBP < 80 mmHg. We found that duration of SBP < 80 mmHg was associated with increased risk of delayed graft function. In DCD donor kidneys of 60 years and older, duration of agonal phase and functional WIT, starting from F I G U R E 4 Trajectories from switch-off until circulatory arrest in combination of period of peripheral oxygen saturation (S p O 2 ) above 60%
and below 60%, and combination of period of systolic blood pressure (SBP) above 80 mmHg and below 80 mmHg. The median cutoffs were <5 minutes for short and ≥5 minutes for long periods of >60% SpO2, and for SpO2 < 60% median cut-offs were <10 minutes for short and ≥10 minutes for long periods. The median cutoffs were <7 minutes for short and ≥7 minutes for long periods of >80 mmHg SBP, and for SBP <80 mmHg median cut-offs were <7 minutes for short and ≥7 minutes for long periods Trajectories from Switch-off (%) SBP < 80 mmHg to cold perfusion, showed to be less important compared to younger donors with outcome of DGF. Surprisingly, period of SpO2 < 60% was not associated with increased risk of delayed graft function, however, period of SpO2 > 60% did significantly influence risk of DGF. Agonal phase parameters as measured in this study were not significantly associated with primary non-function, renal function at three months, and graft failure at three years.
Although it has been suggested that recipients of DCD kidneys with DGF experienced a higher incidence of overall and deathcensored graft loss compared with those without DGF, 10 DGF. 6 Including 409 transplants, we were able to conform that hypotension during agonal phase increased the risk for DGF. It is likely that the small number of events of primary non-function prevented us to reach significance. Allen and colleagues (2015) studied duration as well as the slope and the area under the curve to characterize warm ischemic injury in 1050 DCD donor kidneys. They found no association of duration of SBP < 50 mmHg and SpO2 < 75% with DGF and graft failure. 7 When they took linearity of the trajectory into account by calculating the AUC of SBP, AUC of only SBP above the median showed to be independently associated with DGF. We were not able to calculate AUC of SBP during agonal phase. Instead, to take non-linearity of association into account, we introduced restricted F I G U R E 5 Flexible associations of period SBP <80 mmHg from switch-off until circulatory arrest and PNF (A) and DGF (C), and associations of period that SpO2 < 60% with PNF (B) and DGF (D). In all four models restricted cubic splines were used to plot period of SBP < 80 mmHg and SpO2 <60% with internal knots at 5, 10, and 15 minutes. All models were adjusted for at the median of SBP >80 mmHg (7 minutes) Models are adjusted, corresponding to a donor age of 55 y, cold ischemic time of 16 h, 3 HLA mismatch levels, 30 min anastomosis time, CVA as donor cause of death, 67 mL/min last measured creatinine of the donor, multi-organ-donor, 3.6 y recipient dialysis vintage, and recipient age of 58 y. Restricted cubic splines are used with three defined internal knots at the median and IQR of the predictor variable. CVA, cerebrovascular accident; D.f., degrees of freedom; eGFR, estimated transplant glomerular filtration rate; IQR, interquartile range; MDRD, modification of diet in renal disease; SBP, systolic blood pressure; SpO2, peripheral oxygen saturation; WIT, warm ischemic time. a Only univariate results are shown due to small sample of 27 cases of PNF. b Also adjusted for first WIT at 16 min, time from asystole to cold perfusion. c PNF cases (n = 27) are excluded. d Graft failure cases <3 mo (n = 35) are excluded. eGFR calculated with MDRD formula. e Composite endpoint used for graft failure (graft loss, patient death or eGFR < 15 without improvement after transplantation).
*Indicates P < .05. Other studies have shown that higher donor WIT was associated with graft failure, but not necessarily specifically for marginal DCD kidneys.
TA B L E 3
Odds for DGF according to different DCD donor age and duration
11-13
We show that relatively simple measurements of duration of donor WIT did not predict three-month renal function and graft failure on the long-term. The interplay of donor (eg, warm ischemic injury and inflammatory signaling) and recipient (reperfusion injury and innate and adaptive immune response) derived factors might be far more complex. Counterintuitively, SpO2 > 60% was shown to be associated with increased odds of DGF, and not SpO2 < 60%.
This suggests that longer period of SpO2 > 60%, and thus a more gradual decline in peripheral oxygen saturation has negative impact on the kidney. As we corrected for other donor confounders, this result is not readily explainable given that there is still circulation in this period. Counterintuitive associations of duration of SpO2 and SBP with graft failure were previously described, as was also suggested that WIT based on duration of hemodynamic measures may not be optimal. 7 It has been suggested that brief, reversible episodes of ischemia in one coronary bed may trigger protective factors preventing the kidney from reperfusion injury. 14 These episodes were not included in times of donor WIT, and times may reflect different underlying mechanisms.
Blood pressure can be reliably measured by means of an arterial catheter. However, peripheral oxygen saturation measurement by means of pulse oximetry at the fingertip may reflect oxygenation if the kidney accurately, since peripheral vasoconstriction is common in hemodynamically instable patients in agonal phase. 15 Moreover pulse oximeters are less accurate when oxygen saturation is very low (below ~80%). 16, 17 Our findings suggest that DCD donors with an agonal phase period longer than one hour can be accepted for kidney transplantation, which is in line with other studies. 5, 18, 19 Most recently a US study by Scalea et al 18 showed no differences in graft survival at eight years between DCD kidneys within different categories of agonal phase periods with an upper limit of two hours. In another US center with more liberal protocol (upper agonal phase limit of four hours), Reid et al 5 also did not find graft survival differences between agonal phase duration <1 hour compared with >1 hour. When speculating, agonal phase may be increased to three or four hours, however, it may be questioned whether changing the upper limit to three or four hours is likely to increase the number of DCD donors at a satisfying number that outweigh the costs. In 2016 in the Netherlands, 159 DCD procedures had been started of which 109 DCD donations were effectuated. Of the 50 procedures that were not effectuated, 31 DCD donors did not fulfill the criteria of the two-hour standby time.
Handling an upper limit of four hours, the donor pool could be extended with only two to three eligible DCD donors. The duration of agonal phase is hard to predict, 20 and can last for more than 72 hours. The costs of increasing the limit are related to the recovery teams who have to stand down longer times. 18 Our results are limited in using arbitrary thresholds for systolic blood pressure (<80 mmHg) and saturation (SpO2 < 60%). Other studies suggest to use thresholds for systolic blood pressure of <50 mmHg or saturation <80%, 6, 7, 21 however, to our knowledge this has not been proven yet. 22 Also some studies include minutes of SBP below a certain threshold (mostly 50 mmHg) to the first WIT, referred to as functional WIT. 21 This may be attractive for the purpose of prediction, but may be less feasible to explore associations. Some other limitations should be considered. Firstly, we were unable to adjust for possible confounders for outcome of primary non-function. Secondly, it is likely that more selection bias is present for DCD donor kidneys with longer periods of agonal phase. The present study showed result from the era of static cold storage (SCS).
We conclude that duration of agonal phase is associated with early, but not with long term transplant outcome. Low SBP during agonal phase does influence short term transplant outcome, though low SpO2 measured with pulse oximetry does not. Agonal phase and its parameters require research attention to expand the DCD donor pool safely.
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